These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 7679694)

  • 1. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells.
    Zweerink HJ; Gammon MC; Utz U; Sauma SY; Harrer T; Hawkins JC; Johnson RP; Sirotina A; Hermes JD; Walker BD
    J Immunol; 1993 Mar; 150(5):1763-71. PubMed ID: 7679694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2.
    Robbins PA; Lettice LA; Rota P; Santos-Aguado J; Rothbard J; McMichael AJ; Strominger JL
    J Immunol; 1989 Dec; 143(12):4098-103. PubMed ID: 2480387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
    DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE
    J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides.
    Sutton J; Rowland-Jones S; Rosenberg W; Nixon D; Gotch F; Gao XM; Murray N; Spoonas A; Driscoll P; Smith M
    Eur J Immunol; 1993 Feb; 23(2):447-53. PubMed ID: 7679646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition.
    Matsui M; Moots RJ; Warburton RJ; Peace-Brewer AL; Tussey LG; Quinn DG; McMichael AJ; Frelinger JA
    J Immunol; 1995 Feb; 154(3):1088-96. PubMed ID: 7822785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
    Carreno BM; Turner RV; Biddison WE; Coligan JE
    J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 45 pocket of HLA-A2.1 plays a role in presentation of influenza virus matrix peptide and alloantigens.
    Winter CC; Carreno BM; Turner RV; Koenig S; Biddison WE
    J Immunol; 1991 May; 146(10):3508-12. PubMed ID: 2026879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73.
    Shimojo N; Cowan EP; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
    J Immunol; 1989 Jul; 143(2):558-64. PubMed ID: 2472444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase.
    van der Burg SH; Klein MR; van de Velde CJ; Kast WM; Miedema F; Melief CJ
    AIDS; 1995 Feb; 9(2):121-7. PubMed ID: 7536421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27.
    Bowness P; Allen RL; McMichael AJ
    Eur J Immunol; 1994 Oct; 24(10):2357-63. PubMed ID: 7523137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous loading of HLA-A2 molecules with an analog of the influenza virus matrix protein-derived peptide and its inhibition by an exogenous peptide antagonist.
    Gammon MC; Bednarek MA; Biddison WE; Bondy SS; Hermes JD; Mark GE; Williamson AR; Zweerink HJ
    J Immunol; 1992 Jan; 148(1):7-12. PubMed ID: 1727876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major histocompatibility complex class I-restricted presentation of influenza virus nucleoprotein peptide by B lymphoma cells harboring an antibody gene antigenized with the virus peptide.
    Billetta R; Filaci G; Zanetti M
    Eur J Immunol; 1995 Mar; 25(3):776-83. PubMed ID: 7705408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.
    Bodmer H; Ogg G; Gotch F; McMichael A
    Nature; 1989 Nov; 342(6248):443-6. PubMed ID: 2479838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a human CD8+ T lymphocyte neo-epitope created by a ras codon 12 mutation which is restricted by the HLA-A2 allele.
    Bergmann-Leitner ES; Kantor JA; Shupert WL; Schlom J; Abrams SI
    Cell Immunol; 1998 Aug; 187(2):103-16. PubMed ID: 9732698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2.
    Bednarek MA; Sauma SY; Gammon MC; Porter G; Tamhankar S; Williamson AR; Zweerink HJ
    J Immunol; 1991 Dec; 147(12):4047-53. PubMed ID: 1721637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein.
    Engelhard VH; Lacy E; Ridge JP
    J Immunol; 1991 Feb; 146(4):1226-32. PubMed ID: 1704033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
    Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nucleoprotein peptide of influenza A virus stimulates assembly of HLA-B27 class I heavy chains and beta 2-microglobulin translated in vitro.
    Kvist S; Hamann U
    Nature; 1990 Nov; 348(6300):446-8. PubMed ID: 2247148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes.
    Nijman HW; Houbiers JG; Vierboom MP; van der Burg SH; Drijfhout JW; D'Amaro J; Kenemans P; Melief CJ; Kast WM
    Eur J Immunol; 1993 Jun; 23(6):1215-9. PubMed ID: 7684681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen.
    Milligan GN; Morrison LA; Gorka J; Braciale VL; Braciale TJ
    J Immunol; 1990 Nov; 145(10):3188-93. PubMed ID: 1700000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.